THE PREVALENCE OF BLASTOCYSTIS HOMINIS INFECTION IN OUTPATIENTS AT HO CHI MINH CITY UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL
Main Article Content
Abstract
Background: Blastocystis hominis (B.hominis) is a protozoan commonly found in the human gastrointestinal tract, and its epidemiological characteristics are common in developing countries. Some studies have suggested that this parasite is associated with colonic diseases, especially colorectal cancer. However, data on the infection rate and characteristics of B.hominis are still limited. Method: A descriptive cross-sectional study was conducted on 499 individuals aged 18 and over who underwent microscopy and outpatient examination at the Gastroenterology Clinic - University Medical Center, Ho Chi Minh City from December 2023 to April 2024. B. hominis was assessed through microscopy of stool samples. Data on demographics, clinical symptoms, and microscopy results were collected. Results: The prevalence of B.hominis infection in the study group was 20.4% (102/499). The prevalence was higher in those with positive stool microscopy results for occult blood (29.6% vs. 16.8%, p=0.001) and other intestinal parasites (92.0% vs. 16.7%, p<0.001). In contrast, the prevalence of B. hominis infection was lower in the group with the presence of fungi in the stool (12.9% vs. 22.7%, p = 0.02). Conclusion: The prevalence of B.hominis infection in gastroenterology outpatients in this study is consistent with previous publications on the distribution of this parasite in developing countries. However, further studies using molecular biology techniques are needed to identify the subtype and clarify the role of B.hominis in colonic diseases.
Article Details
Keywords
: prevalence, Blastocystis hominis, outpatient
References
2. Lokmer A, Cian A, Froment A, et al. Use of shotgun metagenomics for the identification of protozoa in the gut microbiota of healthy individuals from worldwide populations with various industrialization levels. PLoS ONE. 2019; 14: e0211139. doi: 10.1371/journal.pone. 0211139.
3. Hussein EM, El-Moamly AA, et al. First epidemiological survey on the prevalence and subtypes distribution of the enteric parasite Blastocystis sp. in Vietnam. Pathogens. 2023; 12(4): 520.
4. Lê Thị Cẩm Ly, Nguyễn Thị Yến Ngọc, Lê Thảo Chân, Trần Gia Nhập, Nguyễn Thị Mỹ Duyên, Đào Lê Mỹ Hạnh. Nghiên cứu tỷ lệ, đặc điểm lâm sàng và cận lâm sàng nhiễm bệnh ký sinh trùng đường ruột trên bệnh nhân nội trú tại Khoa Nội tiêu hóa-huyết học lâm sàng bệnh viện Đa khoa Trung Ương Cần Thơ năm 2022-2023. Tạp chí Y Dược học Cần Thơ. 2024; 72: 193-198.
5. Taghipour A, Rayatdoost E, Bairami A, Bahadory S, Abdoli A. Are Blastocystis hominis and Cryptosporidium spp. playing a positive role in colorectal cancer risk? A systematic review and meta-analysis. Infect Agent Cancer. 2022; 17(1):32.
6. Matovelle C, Tejedor MT, Monteagudo LV, Beltrán A, Quílez J. Prevalence and associated factors of blastocystis sp. infection in patients with gastrointestinal symptoms in Spain: a case-control study. Trop Med Infect Dis. 2022; 7(9): 226.
7. Reh L, Muadica AS, Köster PC, et al. Substantial prevalence of enteroparasites cryptosporidium spp., giardia duodenalis and Blastocystis sp. in asymptomatic schoolchildren in Madrid, Spain. Eurosurveillance. 2019; 24: 1900241.
8. Cheng HS, Haung ZF, Lan WH, Kuo TC, Shin JW. Epidemiology of Blastocystis hominis and other intestinal parasites in a Vietnamese female immigrant population in southern Taiwan. Kaohsiung J Med Sci. 2006; 22(4): 166-170.
9. Torky HA, Eida AM, & El-Malky MF. Prevalence of intestinal parasitic co-infections among Blastocystis hominis infected patients. Journal of the Egyptian Society of Parasitology, 2021, 51(1), 133-139.
10. Puthia MK, Sio SW, Lu J, & Tan KS. Blastocystis r-protease-dependent barrier disruption and interleukin-8 response in a 3D-human intestinal epithelial model. Virulence, 2020, 11(1), 1134-1151.